Related Experiment Videos
Thiazolidinone congeners as central nervous system active agents
M Tripathi1, M Verma, V R Gujrati
1Department of Pharmacology and Therapeutics, King George's Medical College, Lucknow, India.
Arzneimittel-Forschung
|June 1, 1993
Summary
New thiazolidinone derivatives were synthesized and evaluated for central nervous system (CNS) activity. Some compounds demonstrated promising CNS effects, suggesting potential therapeutic applications.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Neuropharmacology
Background:
- Thiazolidinone derivatives are known for diverse biological activities.
- Monoamine oxidase (MAO) is a key target for neurological disorders.
- Developing novel CNS-active agents is crucial for treating neurological conditions.
Purpose of the Study:
- To synthesize novel thiazolidinone derivatives.
- To evaluate the synthesized compounds for monoamine oxidase (MAO) inhibitory activity.
- To assess the in vivo central nervous system (CNS) activities of these compounds.
Main Methods:
- Synthesis of 3-(benzylidene amino)-2-imino-4-thiazolidinones via cyclization of thiosemicarbazones.
- Chemical conversion of intermediates into various thiazolidinone and isothiazolidinone analogs.
- In vitro evaluation of monoamine oxidase (MAO) inhibitory activity.
- In vivo assessment of central nervous system (CNS) effects.
Main Results:
- Successful synthesis of novel thiazolidinone and isothiazolidinone compounds.
- Identification of compounds exhibiting significant monoamine oxidase (MAO) inhibitory potential.
- Demonstration of promising central nervous system (CNS) activities in some synthesized molecules.
- Structure-activity relationships were explored for the tested derivatives.
Conclusions:
- The synthesized thiazolidinone and isothiazolidinone derivatives represent a promising class of compounds for CNS-related research.
- Further investigation into these compounds could lead to the development of new therapeutic agents for neurological disorders.
- The study highlights the potential of these heterocyclic scaffolds in drug discovery.